Soleno Therapeutics
Soleno Therapeutics Inc is a biopharmaceutical company dedicated to developing therapies for rare diseases, with a strong focus on community engagement and innovative solutions. The company values collaboration and integrity, aiming to make a meaningful impact in the lives of those with PWS.
Soleno Therapeutics, a Neurocrine Biosciences company, is focused on the development and commercialization of novel therapeutics for the treatment of rare genetic disorders. Inspired by patients and families around the world, the company works to advance promising research that can make a meaningful difference for individuals living with complex, life-threatening rare diseases with unmet medical needs. Soleno is headquartered in Redwood City, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Soleno Therapeutics.
Sr Manager, Patient Support Services
Gilead Sciences
Corporate Counsel / Senior Corporate Counsel
Soleno
Regional Business Director – Southeast Region
SpringWorks Therapeutics
Associate Director, Drug Substance Development & Manufacturing
Entrada Therapeutics
Associate Director, Clinical Outsourcing
Entrada Therapeutics
Marketing Intern
Ipsen